Acadia Pharma Q3 2024 Earnings Preview
by
Contributor since / Followers
Contributor since / Followers
2 months ago
- Acadia Pharma (NASDAQ:ACAD) is scheduled to announce Q3 earnings results on Wednesday, November 6th, after market close.
- The consensus EPS Estimate is $0.14 and the consensus Revenue Estimate is $248.84M (+17.5% Y/Y).
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 9 downward. Revenue estimates have seen 6 upward revisions and 11 downward.